Search

Your search keyword '"De Guibert, Sophie"' showing total 319 results
Start Over Author "De Guibert, Sophie"
319 results on '"De Guibert, Sophie"'

1. Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial

Author

Guièze, Romain, Ysebaert, Loïc, Roos-Weil, Damien, Fornecker, Luc-Mathieu, Ferrant, Emmanuelle, Molina, Lysiane, Aurran, Thérèse, Clavert, Aline, de Guibert, Sophie, Michallet, Anne-Sophie, Saad, Alain, Drénou, Bernard, Quittet, Philippe, Hivert, Bénédicte, Laribi, Kamel, Gay, Julie, Quinquenel, Anne, Broseus, Julien, Rouille, Valérie, Schwartz, David, Magnin, Benoit, Lazarian, Grégory, Véronèse, Lauren, de Antonio, Marie, Laurent, Camille, Tournilhac, Olivier, Pereira, Bruno, and Feugier, Pierre

Published
2024
Full Text
View/download PDF

2. Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia

Author

Chevallier, Patrice, Leguay, Thibaut, Delord, Marc, Salek, Cyril, Kim, Rathana, Huguet, Françoise, Hicheri, Yosr, Wartiovaara-Kautto, Ulla, Raffoux, Emmanuel, Cluzeau, Thomas, Balsat, Marie, Roth-Guepin, Gabrielle, Tavernier, Emmanuelle, Lepretre, Stephane, Bilger, Karin, Bergugnat, Hugo, Berceanu, Ana, Alexis, Magda, Doubek, Michael, Brissot, Eolia, Hunault-Berger, Mathilde, Lebon, Delphine, Turlure, Pascal, Chantepie, Sylvain, Belhabri, Amine, Wickenhauser, Stefan, Bastie, Jean-Noel, Cacheux, Victoria, Himberlin, Chantal, Banos, Anne, Gardin, Claude, Bonnet, Sarah, Plantier, Isabelle, Pica, Gian Matteo, Escoffre-Barbe, Martine, Boissel, Nicolas, Dombret, Herve, Clappier, Emmanuelle, Rousselot, Philippe, Lebon, Delphine, Charbonnier, Amandine, Assouan, Deborah, Hubert, Amandine, Quint, Marine, Kossi, Fulvia Guenbem, Deruche, Elodie, Hunault, Mathilde, Marie, Céline, Banos, Anne, Robin, Jean-Baptiste, Gay, Julie, Capdupuy, Claudie, Labarrere, Sévérine, Vincent, Edith, Simonet-Boissard, Marion, BeRceanu, Ana, Larosa, Fabrice, Desbrosses, Yohan, Boiteux, Guillaume, Dufour, Vinciane, Tissot, Elise, Braun, Thorsten, Gardin, Pr Claude, Vidal, Valérie, Edouart, Geoffrey, Chantepie, Sylvain, Vilque, Jean-Pierre, Johnson Ansah, Hyacinthe, Lebouvier, Angélique, Zapalovicz, Marie Charlotte, Renault, Léa, Gian Matteo, Pica, Courouau, Alix, Prieur, Fabienne, Dupre, Charlene, Cacheux, Victoria, De Renzis, Benoit, Chaleteix, Carine, Fayard, Amandine, Roy, Gwendoline, Bastie, Jean-Noël, Caillot, Denis, Devaux, Laetitia, Chevallier, Patrice, Lebourgeois, Amandine, Bonnet, Antoine, Peterlin, Pierre, Lok, Anne, Guilllaume, Thierry, Fontaine, Alexis Morice, Turlure, Pascal, Touati, Mohamed, Kennel, Céline, Dmytruck, Natalya, Abraham, Julie, Jaccard, Arnaud, Remenieras, Liliane, Girault, Stéphane, Gourin, Marie Pierre, Penot, Amélie, Moreau, Stéphane, Philipon, Céline, Roche, Delphine, Belhabri, Amine, Gilis, Lila, Virelizier, Nicolas, Michalet, Anne-Sophie, Monfray, Jérémy, Balsat, Marie, Thomas, Xavier, Praire, Aline, Guepin, Gabrielle Roth, Bonmati, Caroline, Moulin, Charline, Jacquet, Caroline, Carpodomi, Anne, Bouillet, Hélène, Carpentier, Odile, Montero, Mélanie, Pires, Aude, Gastaud, Lauris, Gama, Anastasia, Coelle, Céline, Karmout, Sonia, Cluzeau, Thomas, Loschi, Michael, Lechardeur, Jessica, Chokri, Hatroubi, Broussot, Loic, Wickenhauser, Stefan, Waulthier, Agathe, Jourdan, Eric, Scherman, Elodie, Umuhire, Diane, Damiano, Maria Alessandra, Hicheri, Yors, Saillard, Colombe, DʼIncan, Evelyne, Hospital, Marie-Anne, LʼAttention, Jean Laurent, Rabah, Mme Nassima, Cesari, Laura Castillo, Gehlkopf, Eve, Vincent, Laure, Navarro, Robert, Quittet, Philippe, Fegueux, Nathalie, Ceballos, Patrice, Marin, Fanny Baguet, Sabadash, Véra, Alexis, Magda, Ochmann, Marlène, Laboure, Nina Akakelyan, Bembrahmi, Omar, Michel, Olivier, Ouahrawi, Brahim, Brissot, Eolia, Legrand, Olivier, Vekhoff, Anne, Isnard, Françoise, Sa, Sara E., Dombret, Hervé, Raffoux, Emmanuel, Lenguine, Etienne, Rabian, Florence, Lebras, Karine Celli, Fauvaux, Catherine, Leguay, Thibaut, Gros, François-Xavier, Debus, Cazaubiel, Titouan, Melot, Cyril, Dematteis, Valentin, Messina, Antonella, Himberlin, Chantal, Le, Quoc-Hung, Maggi, Lucia, Barre, Martine Escoffre, Moignet, Aline, De Guibert, Sophie, Bernard, Marc, Decaux, Olivier, de la Chapelle, Thierry Lamy, Nimubona, Stanislas, Kadende, Mme Erica, Flavigny, Aloyse, Plantier, Isabelle, Detourmignies, Laurence, Wemeau, Mathieu, Dervite, Isabelle, Dernivoix, Kathy, Camille, Mme, Denizart, Ingrid, Lepretre, Stéphane, Stamatoullas-Bastard, Aspasia, Fontoura, Marie-Laure, Jardin, Fabrice, Menard, Anne-Lise, Camus, Vincent, Lanic, Helene, Contentin, Nathalie, Cardinael, Nathalie, Lemasle-Hue, Emilie, Alani, Mustafa, Lebreton, Pierre, Atia, Youcef, Bilger, Karin, Ledoux, Marie-Pierre, Sonntag, Cécile, Collin, Camille, Tavernier, Emmanuelle, Guyotat, Denis, Soglu, Gilbert, Le Jeune, Caroline, Cornillon, Jérôme, Durieux, Coralie, Lavoué, Céline, Miler, Dorante, Huguet, Françoise, Tavitian, Suzanne, Soldan, Justine, Rousselot, Philippe, Rigaudeau, Sophie, Philippe, Laure, Lambert, Juliette, Besson, Caroline, Cabannes, Aurélie, Longval, Thomas, Taksin, Anne-Laure, Bah, Mariama, BeulayGue, Anaïs, Doubek, Michael, Folber, Frantisek, Hrabovsky, Stepan, Brzonova, Jana, Vejsadova, Hana, Salek, Cyril, Novotova, Elena, Mertova, Jolana, Brzonova, Jana, Vejsadova, Hana, Wartiovaara-Kautto, Ulla, Salonen, Minna, and Vaalas, Saara

Published
2024
Full Text
View/download PDF

3. Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids

Author

Oluwole, Olalekan O., Forcade, Edouard, Muñoz, Javier, de Guibert, Sophie, Vose, Julie M., Bartlett, Nancy L., Lin, Yi, Deol, Abhinav, McSweeney, Peter, Goy, Andre H., Kersten, Marie José, Jacobson, Caron A., Farooq, Umar, Minnema, Monique C., Thieblemont, Catherine, Timmerman, John M., Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Zheng, Yan, Vardhanabhuti, Saran, Nater, Jenny, Shen, Rhine R., Miao, Harry, Kim, Jenny J., and van Meerten, Tom

Published
2024
Full Text
View/download PDF

5. Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

Author

Oluwole, Olalekan O, Bouabdallah, Krimo, Muñoz, Javier, De Guibert, Sophie, Vose, Julie M, Bartlett, Nancy L, Lin, Yi, Deol, Abhinav, McSweeney, Peter A, Goy, Andre H, Kersten, Marie José, Jacobson, Caron A, Farooq, Umar, Minnema, Monique C, Thieblemont, Catherine, Timmerman, John M, Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Kim, Jenny J, Bashir, Zahid, McLeroy, Jeff, Zheng, Yan, Rossi, John M, Johnson, Lisa, Goyal, Lovely, and Meerten, Tom

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Lymphoma, Rare Diseases, Cancer, Hematology, Clinical Research, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Immunological, Biological Products, Cytokine Release Syndrome, Dexamethasone, Female, Humans, Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, large B-cell lymphoma, axi-cel, chimaeric antigen receptor-T cell, prophylaxis, corticosteroids, cytokine release syndrome, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology
Abstract

ZUMA-1 (NCT02348216) examined the safety and efficacy of axicabtagene ciloleucel (axi-cel), an autologous CD19-directed chimaeric antigen receptor (CAR)-T cell therapy, in refractory large B-cell lymphoma. To reduce treatment-related toxicity, several exploratory safety management cohorts were added to ZUMA-1. Specifically, cohort 6 investigated management of cytokine release syndrome (CRS) and neurologic events (NEs) with prophylactic corticosteroids and earlier corticosteroid and tocilizumab intervention. CRS and NE incidence and severity were primary end-points. Following leukapheresis, patients could receive optional bridging therapy per investigator discretion. All patients received conditioning chemotherapy (days -5 through -3), 2 × 106  CAR-T cells/kg (day 0) and once-daily oral dexamethasone [10 mg, day 0 (before axi-cel) through day 2]. Forty patients received axi-cel. CRS occurred in 80% of patients (all grade ≤2). Any grade and grade 3 or higher NEs occurred in 58% and 13% of patients respectively. Sixty-eight per cent of patients did not experience CRS or NEs within 72 h of axi-cel. With a median follow-up of 8·9 months, objective and complete response rates were 95% and 80% respectively. Overall, prophylactic corticosteroids and earlier corticosteroid and/or tocilizumab intervention resulted in no grade 3 or higher CRS, a low rate of grade 3 or higher NEs and high response rates in this study population.

Published
2021

6. A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

Author

Michallet, Anne-Sophie, Letestu, Rémi, Le Garff-Tavernier, Magali, Campos, Lydia, Ticchioni, Michel, Dilhuydy, Marie-Sarah, Morisset, Stephane, Rouille, Valérie, Mahé, Béatrice, Laribi, Kamel, Villemagne, Bruno, Ferrant, Emmanuelle, Tournilhac, Olivier, Delmer, Alain, Molina, Lysiane, Leblond, Véronique, Tomowiak, Cécile, de Guibert, Sophie, Orsini-Piocelle, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan-Graczyk, Margot, Vilque, Jean-Pierre, Schleinitz, Thérèse Aurran, Cymbalista, Florence, Leprêtre, Stéphane, Lévy, Vincent, Nguyen-Khac, Florence, and Feugier, Pierre

Published
2023
Full Text
View/download PDF

7. Remission after CAR T‐cell therapy: Do lymphoma patients recover a normal life?

Author

Perthus, Alya, primary, Colin, Fanny, additional, Charton, Emilie, additional, Anota, Amélie, additional, Lhomme, Faustine, additional, Manson, Guillaume, additional, De Guibert, Sophie, additional, Daufresne, Pierre, additional, Bellec, Adeline, additional, Le Bars, Laetitia, additional, De Barros, Sandra, additional, Ysebaert, Loïc, additional, Merceur, Marianne, additional, Cogné, Mélanie, additional, Lamy De La Chapelle, Thierry, additional, Houot, Roch, additional, and Moignet, Aline, additional

Published
2024
Full Text
View/download PDF

8. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Author

Zafrani, Lara, Mariotte, Eric, Lemiale, Virginie, Arnulf, Bertrand, Boissel, Nicolas, Thieblemont, Catherine, Rabian, Florence, Harel, Stéphanie, Di Blasi, Roberta, Delgado, Julio, Ortiz, Valentin, Blaise, Didier, Fürst, Sabine, Legrand, Faezeh, Chabannon, Christian, Forcade, Edouard, Gros, François-Xavier, Borel, Cécile, Huynh, Anne, Récher, Christian, Rudzki, Jakob, Rakszawski, Kevin, Sesques, Pierre, Bachy, Emmanuel, Salles, Gilles, Perales, Miguel A, Wohlfarth, Philipp, Staudingert, Thomas, Jäger, Ulrich, Cartron, Guillaume, Fégueux, Nathalie, Ceballos, Patrice, Platon, Laura, Gastinne, Thomas, Tessoulin, Benoit, Le Bourgeois, Amandine, Gavrilina, Olga, Sureda, Anna, Mussetti, Alberto, Borrega, Jorge Garcia, Borchmann, Peter, Lin, Yi, Benjamin, Reuben, de Guibert, Sophie, Quelven, Quentin, Yakoub-Agha, Ibrahim, Beauvais, David, Rubio, Marie-Therese, Azoulay, Élie, Castro, Pedro, Maamar, Adel, Metaxa, Victoria, de Moraes, Alice Gallo, Voigt, Louis, Wallet, Florent, Klouche, Kada, Picard, Muriel, Moreau, Anne-Sophie, Van De Louw, Andry, Seguin, Amélie, Mokart, Djamel, Chawla, Sanjay, Leroy, Julien, Böll, Boris, Issa, Nahema, Levy, Bruno, Hemelaar, Pleun, Fernandez, Sara, Munshi, Laveena, Bauer, Philippe, Schellongowski, Peter, Joannidis, Michael, Moreno-Gonzalez, Gabriel, Galstian, Gennadii, Darmon, Michael, and Valade, Sandrine

Published
2021
Full Text
View/download PDF

9. Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma

Author

MS Hematologie, Cancer, Infection & Immunity, van Meerten, Tom, Kuruvilla, John, Song, Kevin W, Thieblemont, Catherine, Minnema, Monique C, Forcade, Edouard, De Guibert, Sophie, Kersten, Marie José, Mutsaers, Pim Gnj, Wermke, Martin, Zheng, Yan, Xue, Allen, Winters, Joshua N, Nater, Jenny, Shen, Rhine R, Spooner, Clare, Neumann, Frank, Kim, Jenny J, Topp, Max S, MS Hematologie, Cancer, Infection & Immunity, van Meerten, Tom, Kuruvilla, John, Song, Kevin W, Thieblemont, Catherine, Minnema, Monique C, Forcade, Edouard, De Guibert, Sophie, Kersten, Marie José, Mutsaers, Pim Gnj, Wermke, Martin, Zheng, Yan, Xue, Allen, Winters, Joshua N, Nater, Jenny, Shen, Rhine R, Spooner, Clare, Neumann, Frank, Kim, Jenny J, and Topp, Max S

Published
2024

10. Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids

Author

MS Hematologie, Cancer, Infection & Immunity, Regenerative Medicine and Stem Cells, Oluwole, Olalekan O, Forcade, Edouard, Muñoz, Javier, de Guibert, Sophie, Vose, Julie M, Bartlett, Nancy L, Lin, Yi, Deol, Abhinav, McSweeney, Peter, Goy, Andre H, Kersten, Marie José, Jacobson, Caron A, Farooq, Umar, Minnema, Monique C, Thieblemont, Catherine, Timmerman, John M, Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Zheng, Yan, Vardhanabhuti, Saran, Nater, Jenny, Shen, Rhine R, Miao, Harry, Kim, Jenny J, van Meerten, Tom, MS Hematologie, Cancer, Infection & Immunity, Regenerative Medicine and Stem Cells, Oluwole, Olalekan O, Forcade, Edouard, Muñoz, Javier, de Guibert, Sophie, Vose, Julie M, Bartlett, Nancy L, Lin, Yi, Deol, Abhinav, McSweeney, Peter, Goy, Andre H, Kersten, Marie José, Jacobson, Caron A, Farooq, Umar, Minnema, Monique C, Thieblemont, Catherine, Timmerman, John M, Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Zheng, Yan, Vardhanabhuti, Saran, Nater, Jenny, Shen, Rhine R, Miao, Harry, Kim, Jenny J, and van Meerten, Tom

Published
2024

11. Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Author

Bouclet, Florian, Calleja, Anne, Dilhuydy, Marie-Sarah, Véronèse, Lauren, Pereira, Bruno, Amorim, Sandy, Cymbalista, Florence, Herbaux, Charles, de Guibert, Sophie, Roos-Weil, Damien, Hivert, Bénédicte, Aurran, Thérèse, Dupuis, Jehan, Blouet, Anaise, Tchernonog, Emmanuelle, Laribi, Kamel, Dmytruck, Nataliya, Morel, Pierre, Michallet, Anne-Sophie, Dartigeas, Caroline, Tournilhac, Olivier, Nguyen-Khac, Florence, Delmer, Alain, Feugier, Pierre, Ysebaert, Loïc, and Guièze, Romain

Published
2021
Full Text
View/download PDF

12. Remote monitoring of CAR T-cell treated patients by a specialized nurse to detect and manage late complications: report of the CARAMA program

Author

Colin, Fanny, primary, Bellec, Adeline, additional, Bars, Laetitia Le, additional, Granger, Magali, additional, Lucas, Leslie, additional, Ricard, Tiphaine, additional, De Guibert, Sophie, additional, Manson, Guillaume, additional, Mear, Jean Baptiste, additional, Lhomme, Faustine, additional, Marchand, Tony, additional, escoffre, martine, additional, Decaux, Olivier, additional, Perthus, Alya, additional, Lamy, Thierry, additional, Houot, Roch, additional, and Moignet-Autrel, aline, additional

Published
2024
Full Text
View/download PDF

13. Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial

Author

Michallet, Anne-Sophie, Dilhuydy, Marie-Sarah, Subtil, Fabien, Rouille, Valerie, Mahe, Beatrice, Laribi, Kamel, Villemagne, Bruno, Salles, Gilles, Tournilhac, Olivier, Delmer, Alain, Portois, Christelle, Pegourie, Brigitte, Leblond, Veronique, Tomowiak, Cecile, de Guibert, Sophie, Orsini, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan Graczyk, Malgorzata, Vilque, Jean P, Aurran, Thérèse, Cymbalista, Florence, Lepretre, Stéphane, Lévy, Vincent, Nguyen-Khac, Florence, Le Garff-Tavernier, Magali, Aanei, Carmen, Ticchioni, Michel, Letestu, Rémi, and Feugier, Pierre

Published
2019
Full Text
View/download PDF

14. Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study

Author

Dartigeas, Caroline, Van Den Neste, Eric, Léger, Julie, Maisonneuve, Hervé, Berthou, Christian, Dilhuydy, Marie-Sarah, De Guibert, Sophie, Leprêtre, Stéphane, Béné, Marie C, Nguyen-Khac, Florence, Letestu, Rémi, Cymbalista, Florence, Rodon, Philippe, Aurran-Schleinitz, Thérèse, Vilque, Jean-Pierre, Tournilhac, Olivier, Mahé, Béatrice, Laribi, Kamel, Michallet, Anne-Sophie, Delmer, Alain, Feugier, Pierre, Lévy, Vincent, Delépine, Roselyne, Colombat, Philippe, and Leblond, Véronique

Published
2018
Full Text
View/download PDF

15. Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study

Author

Houot, Roch, Cartron, Guillaume, Bijou, Fontanet, de Guibert, Sophie, Salles, Gilles A., Fruchart, Christophe, Bouabdallah, Krimo, Maerevoet, Marie, Feugier, Pierre, Le Gouill, Steven, Tilly, Hervé, Casasnovas, Rene-Olivier, Moluçon-Chabrot, Cécile, Van Den Neste, Eric, Zachee, Pierre, Andre, Marc, Bonnet, Christophe, Haioun, Corinne, Van Hoof, Achiel, Van Eygen, Koen, Molina, Lysiane, Nicolas-Virelizier, Emmanuelle, Ruminy, Philippe, and Morschhauser, Franck

Published
2019
Full Text
View/download PDF

16. P1407: REMOTE MONITORING OF CAR T-CELL TREATED PATIENTS BY A SPECIALIZED NURSE TO DETECT AND MANAGE LATE COMPLICATIONS: REPORT OF THE CARAMA PROGRAM

Author

Colin, Fanny, primary, Adeline, Bellec, additional, Le Bars, Laetitia, additional, Granger, Magali, additional, De Guibert, Sophie, additional, Manson, Guillaum, additional, Lhomme, Faustine, additional, Marchand, Tony, additional, Mear, Jean-Baptiste, additional, Escoffre, Martine, additional, Decaux, Olivier, additional, Chapelle, Thierry Lamy De La, additional, Houot, Roch, additional, and Moignet, Aline, additional

Published
2023
Full Text
View/download PDF

17. P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY

Author

Munir, Talha, primary, Shadman, Mazyar, additional, Robak, Tadeusz, additional, R. Brown, Jennifer, additional, Kahl, Brad, additional, Ghia, Paolo, additional, Giannopoulos, Krzysztof, additional, Simkovic, Martin, additional, Österberg, Anders, additional, Laurenti, Luca, additional, Walker, Patricia, additional, Opat, Stephen, additional, Ciepluch, Hanna, additional, Greil, Richard, additional, Hanna, Merit, additional, Tani, Monica, additional, Trneny, Marek, additional, M. Brander, Danielle, additional, W. Flinn, Ian, additional, Grosicki, Sebastian, additional, Verner, Emma, additional, Tedeschi, Alessandra, additional, De Guibert, Sophie, additional, Tumyan, Gayane, additional, Laribi, Kamel, additional, Antonio Garcia Marco, Jose, additional, LI, Jianyong, additional, Tian, Tian, additional, Ramakrishnan, Vanitha, additional, Liu, Yu, additional, Szeto, Andy, additional, Paik, Jason, additional, Cohen, Aileen, additional, Tam, Constantine, additional, and Jurczak, Wojciech, additional

Published
2023
Full Text
View/download PDF

18. Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia

Author

Buske, Christian, primary, Dimopoulos, Meletios A., additional, Grunenberg, Alexander, additional, Kastritis, Efstathios, additional, Tomowiak, Cecile, additional, Mahé, Béatrice, additional, Troussard, Xavier, additional, Hajek, Roman, additional, Viardot, Andreas, additional, Tournilhac, Olivier, additional, Aurran, Therese, additional, Lepretre, Stephane, additional, Zerazhi, Hacene, additional, Hivert, Benedicte, additional, Leblond, Veronique, additional, de Guibert, Sophie, additional, Brandefors, Lena, additional, Garcia-Sanz, Ramon, additional, Gomes da Silva, Maria, additional, Kimby, Eva, additional, Schmelzle, Birgit, additional, Kaszynski, Dajana, additional, Dreyhaupt, Jens, additional, Muche, Rainer, additional, and Morel, Pierre, additional

Published
2023
Full Text
View/download PDF

20. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of Zuma-1 Cohort 6

Author

Oluwole, Olalekan O., primary, Forcade, Edouard, additional, Muñoz, Javier, additional, de Guibert, Sophie, additional, Vose, Julie M., additional, Bartlett, Nancy L., additional, Lin, Yi, additional, Deol, Abhinav, additional, McSweeney, Peter A., additional, Goy, Andre H., additional, Kersten, Marie José, additional, Jacobson, Caron A., additional, Farooq, Umar, additional, Minnema, Monique C., additional, Thieblemont, Catherine, additional, Timmerman, John M., additional, Stiff, Patrick, additional, Avivi, Irit, additional, Tzachanis, Dimitrios, additional, Zheng, Yan, additional, Vardhanabhuti, Saran, additional, Nater, Jenny, additional, Shen, Rhine R., additional, Miao, Harry, additional, Kim, Jenny J., additional, and van Meerten, Tom, additional

Published
2023
Full Text
View/download PDF

21. Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

Author

Guièze, Romain, Robbe, Pauline, Clifford, Ruth, de Guibert, Sophie, Pereira, Bruno, Timbs, Adele, Dilhuydy, Marie-Sarah, Cabes, Maite, Ysebaert, Loïc, Burns, Adam, Nguyen-Khac, Florence, Davi, Frédéric, Véronèse, Lauren, Combes, Patricia, Le Garff-Tavernier, Magali, Leblond, Véronique, Merle-Béral, Hélène, Alsolami, Reem, Hamblin, Angela, Mason, Joanne, Pettitt, Andrew, Hillmen, Peter, Taylor, Jenny, Knight, SamanthaJ.L., Tournilhac, Olivier, and Schuh, Anna

Published
2015
Full Text
View/download PDF

22. A Fixed-Duration Immunochemotherapy Approach Combined with Ibrutinib in CLL Produces Deep and Sustained MRD Responses: 5.5-Year Results from the Icll-07 Filo Trial

Author

Michallet, Anne-Sophie, primary, Letestu, Rémi, additional, Le Garff-Tavernier, Magali, additional, Aanaei, Carmen, additional, Ticchioni, Michel, additional, Dilhuydy, Marie-Sarah, additional, Morisset, Stephane, additional, Rouille, Valérie, additional, Mahé, Béatrice, additional, Laribi, Kamel, additional, Villemagne, Bruno, additional, Ferrant, Emmanuelle, additional, Tournilhac, Olivier, additional, Delmer, Alain, additional, Portois, Christelle, additional, Molina, Lysiane, additional, Leblond, Véronique, additional, Tomowiak, Cécile, additional, de Guibert, Sophie, additional, Orsini, Frederique, additional, Banos, Anne, additional, Carassou, Philippe, additional, Cartron, Guillaume, additional, Fornecker, Luc Mathieu, additional, Ysebaert, Loic, additional, Dartigeas, Caroline, additional, Truchan, Margot, additional, Vilque, Jean-Pierre, additional, Aurran Schleinitz, Therese, additional, Florence, Cymbalista, additional, Leprêtre, Stéphane, additional, Lévy, Vincent, additional, Nguyen Khac, Florence, additional, and Feugier, Pierre, additional

Published
2022
Full Text
View/download PDF

23. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6

Author

Oluwole, Olalekan O., primary, Forcade, Edouard, additional, Muñoz, Javier, additional, de Guibert, Sophie, additional, Vose, Julie M., additional, Bartlett, Nancy L., additional, Lin, Yi, additional, Deol, Abhinav, additional, McSweeney, Peter A., additional, Goy, Andre H., additional, Kersten, Marie José, additional, Jacobson, Caron A., additional, Farooq, Umar, additional, Minnema, Monique C., additional, Thieblemont, Catherine, additional, Timmerman, John, additional, Stiff, Patrick, additional, Avivi, Irit, additional, Tzachanis, Dimitrios, additional, Zheng, Yan, additional, Vardhanabhuti, Saran, additional, Nater, Jenny, additional, Shen, Rhine R., additional, Miao, Harry, additional, Kim, Jenny, additional, and van Meerten, Tom, additional

Published
2022
Full Text
View/download PDF

24. Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group

Author

Guieze, Romain, primary, Ysebaert, Loic, additional, Roos-Weil, Damien, additional, Fornecker, Luc-Matthieu, additional, Ferrant, Emmanuelle, additional, Molina, Lysiane, additional, Aurran-Schleinitz, Thérèse, additional, Clavert, Aline, additional, de Guibert, Sophie, additional, Michallet, Anne-Sophie, additional, Saad, Alain, additional, Drenou, Bernard, additional, Quittet, Philippe, additional, Hivert, Benedicte, additional, Laribi, Kamel, additional, Gay, Julie, additional, Broséus, Julien, additional, Rouille, Valérie, additional, Schwartz, David, additional, Pereira, Bruno, additional, Delmer, Alain, additional, and Feugier, Pierre, additional

Published
2022
Full Text
View/download PDF

25. Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation

Author

Quinquenel, Anne, primary, Letestu, Rémi, additional, Le Garff-Tavernier, Magali, additional, Subtil, Fabien, additional, Aurran-Schleinitz, Therese, additional, Laribi, Kamel, additional, Cymbalista, Florence, additional, Levy, Vincent, additional, Simon, Laurence, additional, Roos-Weil, Damien, additional, Leblond, Véronique, additional, Dilhuydy, Marie-Sarah, additional, Dartigeas, Caroline, additional, Tomowiak, Cecile, additional, Guieze, Romain, additional, Tournilhac, Olivier, additional, Ferrant, Emmanuelle, additional, de Guibert, Sophie, additional, Feugier, Pierre, additional, Merabet, Fatiha, additional, Lepretre, Stephane, additional, Carassou, Philippe, additional, Gay, Julie, additional, Hivert, Bénédicte, additional, Fornecker, Luc Mathieu, additional, Dupuis, Jehan, additional, Molina, Lysiane, additional, Villemagne, Bruno, additional, Cartron, Guillaume, additional, Drenou, Bernard, additional, Mahé, Béatrice, additional, Benbrahim, Omar, additional, Cahu, Xavier, additional, Portois, Christelle, additional, Ysebaert, Loic, additional, Nguyen Khac, Florence, additional, Rouille, Valérie, additional, Delmer, Alain, additional, and Michallet, Anne-Sophie, additional

Published
2022
Full Text
View/download PDF

28. TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

Author

Lazarian, Grégory, Theves, Floriane, Hormi, Myriam, Letestu, Rémi, Eclache, Virginie, Bidet, Audrey, Cornillet-Lefebvre, Pascale, Davi, Frédéric, Delabesse, Eric, Estienne, Marie-Hélène, Etancelin, Pascaline, Kosmider, Olivier, Laibe, Sophy, Lode, Laurence, Muller, Marc, Nadal, Nathalie, Naguib, Dina, Pastoret, Cédric, Poulain, Stéphanie, Sujobert, Pierre, Veronese, Lauren, Imache, Samia, Lefebvre, Valérie, Cymbalista, Florence, Baran-Marszak, Fanny, Soussi, Thierry, Aurran, Thérese, Herbaux, Charles, Cartron, Guillaume, Dartigeas, Caroline, Delmer, Alain, Dupuis, Jehan, Dilhuydy, Marie, Ferrant, Emmanuelle, Feugier, Pierre, Genevieve, Franck, de Guibert, Sophie, Guieze, Romain, Leblond, Véronique, Levy, Vincent, Leprêtre, Stephane, Merabet, Fatiha, Michallet, Anne-Sophie, Nguyen-Khac, Florence, Quinquenel, Anne, Raynaud, Sophie, Re, Daniel, Thieblemont, Catherine, Tournillhac, Olivier, Troussard, Xavier, Truchan-Graczyk, Malgorzata, Willems, Lise, Ysebaert, Loic, Zini, Jean-Marc, Service d'hématologie biologique [Avicenne], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Sorbonne Paris Nord, Adaptateurs de signalisation en hématologie (ASIH), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Sorbonne Paris Nord, Service d'Hématologie [AP-HP Hôpital Saint-Louis], Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'Hématologie Biologique [CHU Bordeaux], CHU Bordeaux [Bordeaux], Service d'hématologie [Reims], Hôpital Robert Debré, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims)-Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service Hématologie - IUCT-Oncopole [CHU Toulouse], Pôle Biologie [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle IUCT [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service d'Hématologie biologique [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Département d'Oncologie Génétique [Rouen] (CLCC Henri Becquerel), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Service d'hématologie biologique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Laboratoire Bio-Santis, Cavaillon, France, Laboratoire d'oncobiologie [CHU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Laboratoire de Génétique Médicale (CHU de Nancy), Centre hospitalier universitaire de Nantes (CHU Nantes), Laboratoire de Génétique Chromosomique et Moléculaire [CHU Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service d'hématologie biologique [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), CHU Pontchaillou [Rennes], Service d'Hématologie Cellulaire [Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service d'Hématologie Cellulaire [Hospices civils de Lyon], Hospices Civils de Lyon, Lyon, France, Hospices Civils de Lyon (HCL), Service de Cytogénétique Médicale [CHU Clermont-Ferrand], CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Mort cellulaire programmée et résistance aux drogues dans les hémopathies malignes = Cell death and Drug Resistance in Hematological Disorders [CRC], Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)-École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Uppsala University, French Innovative Leukemia Organization (Filo), Cancéropole Ille de France. Grant Number: 2019-1-EMERG-22-INSERM 6-1, Service d'Hématologie Biologique [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)-École pratique des hautes études (EPHE), and Gestionnaire, Hal Sorbonne Université

Subjects
[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematology, Mutation, Humans, Chlorambucil, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, Tumor Suppressor Protein p53, Codon, Leukemia, Lymphocytic, Chronic, B-Cell, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2022
Full Text
View/download PDF

29. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 1-Year Follow-up of Zuma-1 Cohort 6 (C6)

Author

Oluwole, Olalekan O., primary, Forcade, Edouard, additional, Muñoz, Javier, additional, de Guibert, Sophie, additional, Vose, Julie M., additional, Bartlett, Nancy L, additional, Lin, Yi, additional, Deol, Abhinav, additional, McSweeney, Peter A, additional, Goy, Andre H., additional, Kersten, Marie José, additional, Jacobson, Caron A., additional, Farooq, Umar, additional, Minnema, Monique C., additional, Thieblemont, Catherine, additional, Timmerman, John M., additional, Stiff, Patrick, additional, Avivi, Irit, additional, Tzachanis, Dimitrios, additional, Kim, Jenny J., additional, Zheng, Yan, additional, Shen, Rhine R, additional, Vardhanabhuti, Saran, additional, and van Meerten, Tom, additional

Published
2022
Full Text
View/download PDF

30. A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

Author

Coiffier, Bertrand, Thieblemont, Catherine, de Guibert, Sophie, Dupuis, Jehan, Ribrag, Vincent, Bouabdallah, Réda, Morschhauser, Franck, Navarro, Robert, Le Gouill, Steven, Haioun, Corinne, Houot, Roch, Casasnovas, Olivier, Holte, Harald, Lamy, Thierry, Broussais, Florence, Payrard, Sandrine, Hatteville, Laurence, and Tilly, Hervé

Published
2016
Full Text
View/download PDF

31. Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study

Author

Loschi, Michael, Porcher, Raphael, Barraco, Fiorenza, Terriou, Louis, Mohty, Mohamad, de Guibert, Sophie, Mahe, Beatrice, Lemal, Richard, Dumas, Pierre-Yves, Etienne, Gabriel, Jardin, Fabrice, Royer, Bruno, Bordessoule, Dominique, Rohrlich, Pierre Simon, Fornecker, Luc Mathieu, Salanoubat, Celia, Maury, Sebastien, Cahn, Jean-Yves, Vincent, Laure, Sene, Thomas, Rigaudeau, Sophie, Nguyen, Stephanie, Lepretre, Anne-Claire, Mary, Jean-Yves, Corront, Bernadette, Socie, Gerard, and de Latour, Regis Peffault

Published
2016
Full Text
View/download PDF

32. Blinatumomab for Patients with Richter's Syndrome: A Multicenter Phase 2 Trial from the Filo Group

Author

Guieze, Romain, primary, Ysebaert, Loic, additional, Roos-Weil, Damien, additional, Molina, Lysiane, additional, Fornecker, Luc Mathieu, additional, Aurran, Thérèse, additional, Michallet, Anne-Sophie, additional, Ferrant, Emmanuelle, additional, Clavert, Aline, additional, Saad, Alain, additional, de Guibert, Sophie, additional, Drenou, Bernard, additional, Quittet, Philippe, additional, Hivert, Bénédicte, additional, Laribi, Kamel, additional, Gay, Julie, additional, Broséus, Julien, additional, Rouille, Valérie, additional, Schwartz, David, additional, Pereira, Bruno, additional, Delmer, Alain, additional, and Feugier, Pierre, additional

Published
2021
Full Text
View/download PDF

33. Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR

Author

Michallet, Anne-Sophie, primary, Quinquenel, Anne, additional, Letestu, Remi, additional, Le Garff-Tavernier, Magali, additional, Subtil, Fabien, additional, Elsensohn, Mad-Helenie, additional, Aurran, Therese, additional, Laribi, Kamel, additional, Cymbalista, Florence, additional, Levy, Vincent, additional, Simon, Laurence, additional, Roos-Weil, Damien, additional, Leblond, Veronique, additional, Dilhuydy, Marie-Sarah, additional, Tomowiak, Cécile, additional, Dartigeas, Caroline, additional, Guieze, Romain, additional, Tournilhac, Olivier, additional, Ferrant, Emmanuelle, additional, de Guibert, Sophie, additional, Feugier, Pierre, additional, Merabet, Fatiha, additional, Leprêtre, Stéphane, additional, Carassou, Philippe, additional, Gay, Julie, additional, Hivert, Bénédicte, additional, Fornecker, Luc Mathieu, additional, Dupuis, Jehan, additional, Molina, Lysiane, additional, Villemagne, Bruno, additional, Cartron, Guillaume, additional, Drenou, Bernard, additional, Mahé, Béatrice, additional, Benbrahim, Omar, additional, Cahu, Xavier, additional, Portois, Christelle, additional, Ysebaert, Loic, additional, Nguyen-Khac, Florence, additional, Rouille, Valérie, additional, and Delmer, Alain, additional

Published
2021
Full Text
View/download PDF

34. Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): One-Year Follow-up of ZUMA-1 Cohort 6 (C6)

Author

Oluwole, Olalekan O., primary, Forcade, Edouard, additional, Muñoz, Javier, additional, de Guibert, Sophie, additional, Vose, Julie M., additional, Bartlett, Nancy L., additional, Lin, Yi, additional, Deol, Abhinav, additional, McSweeney, Peter A., additional, Goy, Andre H., additional, Kersten, Marie José, additional, Jacobson, Caron, additional, Farooq, Umar, additional, Minnema, Monique C., additional, Thieblemont, Catherine, additional, Timmerman, John M., additional, Stiff, Patrick, additional, Avivi, Irit, additional, Tzachanis, Dimitrios, additional, Kim, Jenny J., additional, Zheng, Yan, additional, Shen, Rhine R., additional, Vardhanabhuti, Saran, additional, and Van Meerten, Tom, additional

Published
2021
Full Text
View/download PDF

36. A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial

Author

Michallet, Anne-Sophie, Letestu, Rémi, Le Garff-Tavernier, Magali, Aanei, Carmen, Ticchioni, Michel, Dilhuydy, Marie-Sarah, Subtil, Fabien, Rouille, Valerie, Mahe, Beatrice, Laribi, Kamel, Villemagne, Bruno, Salles, Gilles, Tournilhac, Olivier, Delmer, Alain, Portois, Christelle, Pegourie, Brigitte, Leblond, Veronique, Tomowiak, Cecile, De Guibert, Sophie, Orsini Piocelle, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc-Matthieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan-Graczyk, Malgorzata, Vilque, Jean-Pierre, Aurran, Thérèse, Cymbalista, Florence, Lepretre, Stéphane, Levy, Vincent, Nguyen-Khac, Florence, and Feugier, Pierre

Published
2021
Full Text
View/download PDF

37. ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results

Author

Janakiram, Murali, primary, Depaus, Julien, additional, Wagner-Johnston, Nina, additional, Zinzani, Pier Luigi, additional, Phillips, Tycel J., additional, Maly, Joseph, additional, Ferrari, Silvia, additional, Bryan, Locke J., additional, Delwail, Vincent, additional, de Guibert, Sophie, additional, Tani, Monica, additional, Dai, Vivian, additional, Havenith, Karin, additional, Boni, Joseph, additional, He, Xiaomin, additional, Ervin-Haynes, Annette, additional, and Carlo-Stella, Carmelo, additional

Published
2021
Full Text
View/download PDF

38. Poster: ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results

Author

Janakiram, Murali, primary, Depaus, Julien, additional, Wagner-Johnston, Nina, additional, Zinzani, Pier Luigi, additional, Phillips, Tycel J., additional, Maly, Joseph, additional, Ferrari, Silvia, additional, Bryan, Locke J., additional, Delwail, Vincent, additional, De Guibert, Sophie, additional, Tani, Monica, additional, Dai, Vivian, additional, Havenith, Karin, additional, Boni, Joseph, additional, He, Xiaomin, additional, Ervin-Haynes, Annette, additional, and Carlo-Stella, Carmelo, additional

Published
2021
Full Text
View/download PDF

39. Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma

Author

MS Hematologie, Infection & Immunity, Regenerative Medicine and Stem Cells, Cancer, Oluwole, Olalekan O, Bouabdallah, Krimo, Muñoz, Javier, De Guibert, Sophie, Vose, Julie M, Bartlett, Nancy L, Lin, Yi, Deol, Abhinav, McSweeney, Peter A, Goy, Andre H, Kersten, Marie José, Jacobson, Caron A, Farooq, Umar, Minnema, Monique C, Thieblemont, Catherine, Timmerman, John M, Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Kim, Jenny J, Bashir, Zahid, McLeroy, Jeff, Zheng, Yan, Rossi, John M, Johnson, Lisa, Goyal, Lovely, van Meerten, Tom, MS Hematologie, Infection & Immunity, Regenerative Medicine and Stem Cells, Cancer, Oluwole, Olalekan O, Bouabdallah, Krimo, Muñoz, Javier, De Guibert, Sophie, Vose, Julie M, Bartlett, Nancy L, Lin, Yi, Deol, Abhinav, McSweeney, Peter A, Goy, Andre H, Kersten, Marie José, Jacobson, Caron A, Farooq, Umar, Minnema, Monique C, Thieblemont, Catherine, Timmerman, John M, Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Kim, Jenny J, Bashir, Zahid, McLeroy, Jeff, Zheng, Yan, Rossi, John M, Johnson, Lisa, Goyal, Lovely, and van Meerten, Tom

Published
2021

40. Lenalidomide Consolidation Improves Measurable Residual Disease (MRD) Rates and Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - Final Analysis of CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)

Author

Aurran-Schleinitz, Therese, Mulligan, Stephen P, Letestu, Remi, Bene, Marie Christine, Cull, Gavin, Vilque, Jean Pierre, Tam, Constantine S., De Guibert, Sophie, Harrup, Rosemary Anne, Drenou, Bernard, Grigg, Andrew P, Voillat, Laurent, Butcher, Belinda E, Dartigeas, Caroline, Eek, Richard, Daguindau, Nicolas, Forsyth, Cecily, Tiab, Mourad, Smith, Delaine, Curnow, Jennifer, Leblond, Veronique, Larsen, Stephen Robert, Cymbalista, Florence, and Gottlieb, David

Published
2023
Full Text
View/download PDF

41. Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group

Author

Michallet, Anne-Sophie, Quinquenel, Anne, Letestu, Remi, Magali, Tavernier, Morisset, Stéphane, Aurran, Therese, Laribi, Kamel, Cymbalista, Florence, Levy, Vincent, Simon, Laurence, Roos Weil, Damien, Leblond, Veronique, Dilhuydy, Marie Sarah, Tomowiak, Cecile, Dartigeas, Caroline, Guieze, Romain, Tournilhac, Olivier, Ferrant, Emmanuelle, De Guibert, Sophie, Feugier, Pierre, Merabet, Fatiha, Lepretre, Stéphane, Carassou, Philippe, Gay, Julie, Hivert, Benedicte, Fornecker, Luc Matthieu, Dupuis, Jehan, Molina, Lysiane, Villemagne, Bruno, Cartron, Guillaume, Drenou, Bernard, Mahé, Béatrice, Benbrahim, Omar, Cahu, Xavier, Portois, Christelle, Ysebaert, Loic, Nguyen Khac, Florence, Rouillé, Valerie, and Delmer, Alain Jacques

Published
2023
Full Text
View/download PDF

45. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Author

Azoulay, Élie, primary, Castro, Pedro, additional, Maamar, Adel, additional, Metaxa, Victoria, additional, de Moraes, Alice Gallo, additional, Voigt, Louis, additional, Wallet, Florent, additional, Klouche, Kada, additional, Picard, Muriel, additional, Moreau, Anne-Sophie, additional, Van De Louw, Andry, additional, Seguin, Amélie, additional, Mokart, Djamel, additional, Chawla, Sanjay, additional, Leroy, Julien, additional, Böll, Boris, additional, Issa, Nahema, additional, Levy, Bruno, additional, Hemelaar, Pleun, additional, Fernandez, Sara, additional, Munshi, Laveena, additional, Bauer, Philippe, additional, Schellongowski, Peter, additional, Joannidis, Michael, additional, Moreno-Gonzalez, Gabriel, additional, Galstian, Gennadii, additional, Darmon, Michael, additional, Valade, Sandrine, additional, Zafrani, Lara, additional, Mariotte, Eric, additional, Lemiale, Virginie, additional, Arnulf, Bertrand, additional, Boissel, Nicolas, additional, Thieblemont, Catherine, additional, Rabian, Florence, additional, Harel, Stéphanie, additional, Di Blasi, Roberta, additional, Delgado, Julio, additional, Ortiz, Valentin, additional, Blaise, Didier, additional, Fürst, Sabine, additional, Legrand, Faezeh, additional, Chabannon, Christian, additional, Forcade, Edouard, additional, Gros, François-Xavier, additional, Borel, Cécile, additional, Huynh, Anne, additional, Récher, Christian, additional, Rudzki, Jakob, additional, Rakszawski, Kevin, additional, Sesques, Pierre, additional, Bachy, Emmanuel, additional, Salles, Gilles, additional, Perales, Miguel A, additional, Wohlfarth, Philipp, additional, Staudingert, Thomas, additional, Jäger, Ulrich, additional, Cartron, Guillaume, additional, Fégueux, Nathalie, additional, Ceballos, Patrice, additional, Platon, Laura, additional, Gastinne, Thomas, additional, Tessoulin, Benoit, additional, Le Bourgeois, Amandine, additional, Gavrilina, Olga, additional, Sureda, Anna, additional, Mussetti, Alberto, additional, Borrega, Jorge Garcia, additional, Borchmann, Peter, additional, Lin, Yi, additional, Benjamin, Reuben, additional, de Guibert, Sophie, additional, Quelven, Quentin, additional, Yakoub-Agha, Ibrahim, additional, Beauvais, David, additional, and Rubio, Marie-Therese, additional

Published
2021
Full Text
View/download PDF

46. Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Author

Letestu, Rémi, Dahmani, Abdelmalek, Boubaya, Marouane, Baseggio, Lucile, Campos, Lydia, Chatelain, Bernard, Debliquis, Agathe, Drénou, Bernard, Jacob, Marie-Christine, Legac, Eric, Le Garff-Tavernier, Magali, Lhoumeau, Anne-Catherine, Quiney, Claire, Robillard, Nelly, Ticchioni, Michel, Aanei, Carmen, Katsahian, Sandrine, Delepine, Roselyne, Vaudaux, Sandrine, Rouillé, Valérie, Béné, Marie-Christine, Dartigeas, Caroline, Van Den Neste, Eric, Leprêtre, Stéphane, Feugier, Pierre, Cartron, Guillaume, Leblond, Véronique, Lévy, Vincent, Cymbalista, Florence, Cailleres, Sylvie, Damaj, Gandhi, Royer, Bruno, Gardembas, Martine, Dib, Mamoun, Truchan-Graczyk, Matgorzata, Hunault, Mathilde, Foussard, Charles, Corront, Bernadette, Parry, Anne, Orsini-Piocelle, Frédérique, Trouillier, Sébastien, Slama, Bohiane, Lepeu, Gérard, Zerazhi, Hacene, Boulat, Olivier, Azzedine, Ahmed, Araujo, Carla, Banos, Anne, Bauduer, Frédéric, Dutel, Jean-Luc, Ghomari, Kamel, Deconinck, Eric, Brion, Annie, Vuillier, Jacqueline, Saad, Alain, El Yamani, Abderrazak, Rodon, Philippe, Soubeyran, Pierre, Etienne, Gabriel, Dilhuydy, Marie-Sarah, Bouabdallah, Krimo, Leguay, Thibaut, Chouffi, Bachra, Pollet, Bertrand, Maakaroun, Abdallah, Guillerm, Gaëlle, Berthou, Christian, Cheron, Nathalie, ANDRÉ, Marc, Vilque, Jean Pierre, Fruchart, Christophe, Voillat, Laurent, Pica, Gian Matteo, Corm, Sélim, Micléa, Jean-Michel, Souleau, Bertrand, Molucon-Chabrot, Cécile, De Renzis, Benoit, Tournilhac, Olivier, Bay, Jacques-Olivier, Chaleteix, Carine, Guieze, Romain, Fleury, Joel, Precupanu, Cristina, Bouledroua, Selwa, Haiat, Stéphanie, Petitdidier, Charlotte, Dupuis, Jehan, Belhadj, Karim, Casasnovas, Olivier, Bastie, Jean-Noel, Ferrant, Emmanuelle, Gholam, Dany, Molina, Lysiane, Garban, Frédéric, Tiab, Mourad, Maisonneuve, Hervé, Villemagne, Bruno, Jacomy, Dominique, Besson, Caroline, Tertian, Gérard, Laribi, Kamel, Morel, Pierre, Cazin, Bruno, Moreau, Stéphane, Reminieras, Liliane, Rapp, Marie-José, Moreau, Philippe, Sebban, Catherine, Michallet, Anne-Sophie, Salles, Gilles, Broussais, Florence, Aurran-Schleinitz, Thérèse, Coso, Diane, Abarah, Wajed, Kulekci, Claire, Dorvaux, Véronique, Carassou, Philippe, Guibaud, Isabelle, Christian, Bernard, Graux, Carlos, Rossi, Jean-François, Quittet, Philippe, Dubois, Alain, Eisenmann, Jean-Claude, Morineau, Nadine, Mahé, Béatrice, Karsenti, Jean-Michel, Jourdan, Eric, Legouffe, Eric, Alexis-Vigier, Magda, Boulet, Jean-Michel, Aoudjhane, Malek, Thiéblemont, Catherine, Andreoli, Anna Lisa, Dreyfus, François, Choquet, Sylvain, Maloum, Karim, Merle-Béral, Hélène, Vekhoff, Anne, Decaudin, Didier, Brault, Philippe, Delarue, Richard, Janvier, Maud, Soussain, Carole, Vallantin, Xavier, Sanhes, Laurence, Dreyfus, Brigitte, Tomowiak, Cécile, Benramdane, Riad, Gonzalez, Hugo, Blaise-Brenna, Anne, Kolb, Brigitte, Delmer, Alain, Dauriac, Charles, Houot, Roch, Escoffre-Barbe, Martine, Lamy, Thierry, De Guibert, Sophie, Bernard, Marc, Grosbois, Bernard, Brehar, Oana, Morice, Patrick, Guyotat, Denis, Jaubert, Jérome, Portois, Christelle, Fornecker, Luc-Matthieu, Herbrecht, Raoul, Bilger, Karin, Ame, Shanti, Ysebaert, Loic, Godmer, Pascal, Jardel, Henry, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Saint-Etienne, CHU UCL Namur, Groupe hospitalier de la région de Mulhouse Sud-Alsace (GHRMSA), CHU Grenoble, Centre Hospitalier Régional d'Orléans (CHRO), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Hospitalier Universitaire de Nice (CHU Nice), Hopital Saint-Louis [AP-HP] (AP-HP), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université Catholique de Louvain = Catholic University of Louvain (UCL), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Montpellier (UM), UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/DDUV/BCHM - Biochimie-Recherche métabolique, UCL - (MGD) Laboratoire de biologie clinique, UCL - (SLuc) Service d'hématologie, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), and Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)

Subjects
0301 basic medicine, Male, Cancer Research, Neoplasm, Residual, MESH: Immunotherapy, Chronic lymphocytic leukemia, Gastroenterology, MESH: Clinical Trials, Phase III as Topic, 0302 clinical medicine, Bone Marrow, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, MESH: Leukemia, Lymphocytic, Chronic, B-Cell, MESH: Aged, education.field_of_study, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, MESH: Follow-Up Studies, Prognosis, 3. Good health, Fludarabine, Survival Rate, Leukemia, MESH: Antineoplastic Combined Chemotherapy Protocols, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, MESH: Vidarabine, MESH: Bone Marrow, Female, MESH: Rituximab, Immunotherapy, Rituximab, MESH: Clinical Trials, Phase II as Topic, Vidarabine, medicine.drug, medicine.medical_specialty, Cyclophosphamide, MESH: Survival Rate, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Prognosis, 03 medical and health sciences, Clinical Trials, Phase II as Topic, Chemoimmunotherapy, Internal medicine, medicine, Humans, education, Survival rate, MESH: Neoplasm, Residual, Aged, Retrospective Studies, MESH: Humans, business.industry, MESH: Cyclophosphamide, MESH: Retrospective Studies, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, MESH: Male, body regions, 030104 developmental biology, Clinical Trials, Phase III as Topic, Bone marrow, business, MESH: Female, Follow-Up Studies
Abstract

International audience; Measurable residual disease (MRD) status is widely adopted in clinical trials in patients with chronic lymphocytic leukemia (CLL). Findings from FILO group trials (CLL2007FMP, CLL2007SA, CLL2010FMP) enabled investigation of the prognostic value of high-sensitivity (0.7 × 10-5) MRD assessment using flow cytometry, in blood (N = 401) and bone marrow (N = 339), after fludarabine, cyclophosphamide, and rituximab (FCR)-based chemoimmunotherapy in a homogeneous population with long follow-up (median 49.5 months). Addition of low-level positive MRD

Published
2020
Full Text
View/download PDF

48. Prophylactic Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)

Author

Oluwole, Olalekan O., primary, Bouabdallah, Krimo, additional, Muñoz, Javier, additional, De Guibert, Sophie, additional, Vose, Julie M., additional, Bartlett, Nancy L., additional, Lin, Yi, additional, Deol, Abhinav, additional, McSweeney, Peter A., additional, Goy, Andre H., additional, Kersten, Marie José, additional, Jacobson, Caron A., additional, Farooq, Umar, additional, Minnema, Monique C., additional, Thieblemont, Catherine, additional, Timmerman, John M., additional, Stiff, Patrick, additional, Avivi, Irit, additional, Tzachanis, Dimitrios, additional, Kim, Jenny J., additional, Bashir, Zahid, additional, McLeroy, Jeff, additional, Goyal, Lovely, additional, Johnson, Lisa, additional, Zheng, Yan, additional, and van Meerten, Tom, additional

Published
2021
Full Text
View/download PDF

49. 507 - Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of Zuma-1 Cohort 6

Author

Oluwole, Olalekan O., Forcade, Edouard, Muñoz, Javier, de Guibert, Sophie, Vose, Julie M., Bartlett, Nancy L., Lin, Yi, Deol, Abhinav, McSweeney, Peter A., Goy, Andre H., Kersten, Marie José, Jacobson, Caron A., Farooq, Umar, Minnema, Monique C., Thieblemont, Catherine, Timmerman, John M., Stiff, Patrick, Avivi, Irit, Tzachanis, Dimitrios, Zheng, Yan, Vardhanabhuti, Saran, Nater, Jenny, Shen, Rhine R., Miao, Harry, Kim, Jenny J., and van Meerten, Tom

Published
2023
Full Text
View/download PDF

50. Phase 1 Study of CD19 Targeted 4-1BBL Costimulatory Agonist to Enhance T Cell (Glofitamab Combination) or NK Cell Effector Function (Obinutuzumab Combination) in Relapsed/Refractory B Cell Lymphoma

Author

Hutchings, Martin, primary, Offner, Fritz C., additional, Bosch, Francesc, additional, Gritti, Giuseppe, additional, Carlo-Stella, Carmelo, additional, Walter, Harriet, additional, Townsend, William, additional, Morschhauser, Franck, additional, Cartron, Guillaume, additional, Ghesquieres, Hervé, additional, de Guibert, Sophie, additional, Herter, Sylvia, additional, Korfi, Koorosh, additional, Craine, Veronica, additional, Mycroft, Sarah Louise, additional, Whayman, Matt, additional, Mueller, Claudia, additional, Dimier, Natalie, additional, Moore, Tom, additional, Belli, Sara, additional, Kornacker, Martin, additional, Lechner, Katharina, additional, and Dickinson, Michael, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results